PET with L-[1-Carbon-11]-tyrosine to visualize tumors and measure protein synthesis rates

Journal of Nuclear Medicine

Volumn 38, Issue 2, 1997, Pages 191-195

  Kole, Annemieke C ^a   Pruim, Jan ^b   Nieweg, Omgo E ^b   Van Ginkel, Robert J ^b   Hoekstra, Harald J ^b   Koops, Heimen Schraffordt ^b   Vaalburg, Willem ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

carbon 11 tyrosine; PET; protein synthesis rate

Indexed keywords

CARBON 11; TYROSINE DERIVATIVE;

ARTICLE; CANCER DIAGNOSIS; CHONDROSARCOMA; DIAGNOSTIC IMAGING; HEMANGIOMA; NEURILEMOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TUMOR DIAGNOSIS;

ADULT; AGED; CARBON RADIOISOTOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROTEIN BIOSYNTHESIS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0031053737     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Sasaki Y. Monitoring tumor radiotherapy. J Nucl Med 1991;32:2124-2125.
2. Royal HD. Clinical applications of positron emission tomography in cancer: the good, the bad and the ugly. J Nucl Med 1992;33:330-332.
3. Braams JW, Pruim J, Freling NJM, et al. Detection of lymph node metastases of squamous cell cancer in the head and neck with PET-FDG and MRI. J Nucl Med 1995;36:211-216.
4. Macfarlane DJ, Cotton L, Ackermann RJ, et al. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995;194:425-429.
5. Hawkins RA, Phelps ME. PET in clinical oncology. Cancer Metast Rev 1988;7:119-142.
6. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972-1980.
7. Lewis P, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1995;35:1647-1649.
8. 14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. J Nucl Med 1988;27:524-529.
9. 11C]methionine. Jpn J Cancer Res 1989;80:778-782.
10. Sato T, Fujiwara T, Abe Y, et al. Double-tracer whole-body autoradiography using a short-lived positron emitter and a long-lived beta emitter [Abstract]. Radioisotopes 1989;38:7-12.
11. Schober O, Meyer G-J, Duden C, et al. Uptake of amino acids in brain tumors using positron emission tomography as an indicator for assessing metabolic activity and malignancy. Fortschr Rôntgenstr 1987;147:503-509.
12. Derlon J-M, Bourdet C, Bustany P, et al. Carbon-11-L-methionine uptake in gliomas. Neurosurgery 1989;25:720-728.
13. Lilja A, Lundqvist H, Olsson Y, Spännare B, Gullberg P, Långström B. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol 1989; 30:121-128.
14. 11C-labeled amino acids in Walker 256 carcinosarcoma-bearing rats. J Nucl Med Biol 1991;18:197-204.
15. 11C]methionine for measuring in vivo protein synthesis rates with PET. J Nucl Med 1988;29:1419-1427.
16. 13C]methionine. Am J Physiol 1988;255:E322-E331.
17. Bolster JM, Vaalburg W, Paans AM, et al. Carbon-11-labeled tyrosine to study tumor metabolism by positron emission tomography (PET). Eur J Nucl Med 1986;12:321-324.
18. Keen RE, Barrio JR, Huang S-C, Hawkins RA, Phelps ME. In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical to structure tracer kinetic models for positron emission tomography. J Cereb Blood Flow Metab 1989;9:429-445.
19. Phelps ME, Barrio JR, Huang S-C, Keen RA, Chugani H, Mazziotta JC. Criteria for the tracer kinetic measurement of cerebral protein synthesis in humans with positron emission tomography. Ann Neurol 1984;15(suppl):S192-S202.
20. Paans AMJ, Elsinga PH, Vaalburg W. Carbon-11-labeled tyrosine as a probe for modelling the protein synthesis rate. In: Mazoyer BM, Heiss WD, Comar D, eds. PET studies on amino acid metabolism and protein synthesis. Dordrecht: Kluwer; 1993: 161-174.
21. 11C]-tyrosine and positron emission tomography: methods, metabolism, modeling and results in patients with primary or recurrent brain tumors. J Nucl Med 1995;36:411-419.
22. 11C]-tyrosine PET for visualization of brain tumors and quantitation of the protein synthesis rate. Radiology 1995;197:221-226.
23. 11C]cyanide. J Lab Compd Radiopharm 1992;31:207-217.
24. 18F]fluorotyrosine in tumor bearing mice. Nucl Med Biol 1993;20:895-899.
25. Ishiwata K, Kubota K, Murakami M, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 1993;34:1936-1943.
26. Carnochan P, Deehan B, Trivedi M, Tombs A, Sandle J, Ott R. Uptake of radiolabeled tyrosine and iodo-methyl tyrosine in experimental rat tumors; influence of blood flow and tumor growth rate. J Nucl Biol Med 1994;38(suppl 1):92-95.
27. Bradbury MWB, Patlak CS, Oldendorf WH. Analysis of brain uptake and loss of radiotracers after intracarotid injection. Am J Physiol 1975;229:1110-1115.
28. Oldendorf WH. Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Am J Physiol 1991;221:1629-1639.